ACIP retreats from plans to end mRNA Covid vaccine guidance amid midterm politics
A U.S. vaccine advisory panel paused efforts pushed by Kennedy-aligned advisers to end federal recommendations for Covid-19 mRNA vaccines, with officials saying the policy remains on the immunization schedule under shared clinical decision-making. The move appears driven by political sensitivity ahead of the midterms and concerns about the panel’s authority, as leadership changes at the FDA and broader vaccine policy debates continue to shape how Moderna and Pfizer-BioNTech vaccines are framed and used.